About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is Moderna a Good Vaccine Stock to Own in 2022?
The sale of COVID-19 vaccines helped Moderna’s (MRNA) revenue soar over the past few quarters. However, its shares plunged nearly 14% in price on December 10 after disappointing results from its experimental seasonal flu shot. So, let’s discuss if it is wise to buy the dip in the stock with the advent of the COVID-19 omicron variant. Read on.
Should You Buy the Dip in Denison Mines?
Canadian uranium exploration company Denison Mines (DNN) reported top- and bottom-line growth in its last reported quarter. However, its shares have lost more than 30% in price since hitting their 52-week high of $2.14 on Nov. 10. So, is it wise to buy the dip in the stock despite falling uranium prices? Read on.
Should You Buy Smith & Wesson Brands on its Post-Earnings Dip?
The shares of firearm company Smith & Wesson Brands (SWBI) declined nearly 30% in price on December 3, due primarily to investors’ pessimism about the company’s weaker-than-expected second-quarter earnings. Nevertheless, let’s evaluate if it is wise to buy the dip in the stock now based on the company’s consistent product launches. Read on.
Is Fastly a Good Content Delivery Network and Security Software Stock to Own?
Content delivery network and software company Fastly (FSLY) reported revenue growth of nearly 23% in its last reported quarter. However, its stock is currently trading near its 52-week low of $33.55. So, let’s find out if it is wise to add the stock to one’s portfolio now even though the smart money’s interest in the name has declined recently. Read on.
Is Marvell Technology a Buy After Posting Better-Than-Expected Q3 Earnings?
The shares of semiconductor company Marvell Technology (MRVL) soared to their $88.49 all-time price high on December 3, 2021, driven by better-than-expected third-quarter earnings. But can the stock continue to rally despite the intense competition the company faces? Let’s find out.
Should You Buy the Post Earnings Dip in DocuSign?
Software company DocuSign’s (DOCU) shares lost nearly 42% in price on December 3 and hit their 52-week low of $131.51. But can the stock rebound based on the company’s dominant market position and consistent product and services solutions? Let’s find out.
Is Clover Health a Good Buy Under $5?
Healthcare technology company Clover Health (CLOV) has been subject to several investigations since its stock market debut via an SPAC in January 2021. Its stock is currently trading below $5. So, is it wise to bet on the stock now based on the company’s expanding reach? Let’s find out.
Is FuelCell a Buy Under $10?
Clean energy company FuelCell (FCEL) expanded its collaboration with Exxon Mobil (XOM) last month, and many also expect the recently passed U.S. infrastructure bill to benefit the company. However, the stock is currently trading significantly below its 52-week high of $29.44, closing yesterday’s trading session at $7.97. So, let’s evaluate if it is wise to buy the dip in the stock now. Read on.
Is Bridgeline Digital a Good Tech Stock to Add to Your Portfolio?
While technology company Bridgeline Digital’s (BLIN) top line surged in its last reported quarter, the company’s losses widened. So, is it wise to add the stock to one’s portfolio based on the company’s consistent product and services innovation? Let’s discuss. Read on.